Vascular endothelial growth factor-A and platelet-derived growth factor-B combination gene therapy prolongs angiogenic effects via recruitment of interstitial mononuclear cells and paracrine effects rather than improved pericyte coverage of angiogen (Q44665492)

From Wikidata
Jump to navigation Jump to search
scientific article published on 2 October 2008
  • Vascular endothelial growth factor-A and platelet-derived growth factor-B combination gene therapy prolongs angiogenic effects via recruitment of interstitial mononuclear cells and paracrine effects rather than improved pericyte coverage of angiogeni
edit
Language Label Description Also known as
English
Vascular endothelial growth factor-A and platelet-derived growth factor-B combination gene therapy prolongs angiogenic effects via recruitment of interstitial mononuclear cells and paracrine effects rather than improved pericyte coverage of angiogen
scientific article published on 2 October 2008
  • Vascular endothelial growth factor-A and platelet-derived growth factor-B combination gene therapy prolongs angiogenic effects via recruitment of interstitial mononuclear cells and paracrine effects rather than improved pericyte coverage of angiogeni

Statements

Vascular endothelial growth factor-A and platelet-derived growth factor-B combination gene therapy prolongs angiogenic effects via recruitment of interstitial mononuclear cells and paracrine effects rather than improved pericyte coverage of angiogen (English)
1 reference
Johanna Kilpijoki
1 reference
Peter Baluk
1 reference
Donald M McDonald
1 reference
Yihai Cao
1 reference
Ulf Eriksson
1 reference
2 October 2008
1 reference
103
1 reference
10
1 reference
1092-1099
1 reference

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit